1. Home
  2. BSX vs BX Comparison

BSX vs BX Comparison

Compare BSX & BX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

HOLD

Current Price

$69.33

Market Cap

137.8B

Sector

Health Care

ML Signal

HOLD

Logo Blackstone Inc.

BX

Blackstone Inc.

HOLD

Current Price

$107.21

Market Cap

116.4B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSX
BX
Founded
1979
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
137.8B
116.4B
IPO Year
2010
2007

Fundamental Metrics

Financial Performance
Metric
BSX
BX
Price
$69.33
$107.21
Analyst Decision
Strong Buy
Buy
Analyst Count
20
16
Target Price
$108.75
$169.50
AVG Volume (30 Days)
10.7M
8.8M
Earning Date
01-01-0001
04-30-2026
Dividend Yield
N/A
4.42%
EPS Growth
55.20
6.91
EPS
1.94
3.87
Revenue
$9,076,000,000.00
$14,450,265,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$10.48
$21.75
P/E Ratio
$35.98
$27.66
Revenue Growth
12.49
9.22
52 Week Low
$67.56
$101.73
52 Week High
$109.50
$190.09

Technical Indicators

Market Signals
Indicator
BSX
BX
Relative Strength Index (RSI) 33.05 34.02
Support Level N/A $105.09
Resistance Level $76.77 $165.14
Average True Range (ATR) 1.80 4.53
MACD 0.14 0.11
Stochastic Oscillator 24.51 28.06

Price Performance

Historical Comparison
BSX
BX

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

About BX Blackstone Inc.

Blackstone is the world's largest alternative-asset manager with $1.242 trillion in total asset under management, including $906.2 billion in fee-earning assets under management, at the end of September 2025. The company operates with scale in each of its major product lines: private equity (26% of fee-earning AUM and 33% of base management fees), real estate/real assets (31% and 35%), private credit (34% and 25%), and other alternatives (9% and 7%). While the firm primarily serves institutional investors (84% of AUM), it also caters to clients in the high-net-worth channel (16%). Blackstone operates through 25 offices in the Americas (8), Europe and the Middle East (9), and the Asia-Pacific region (8).

Share on Social Networks: